Genoveva Uzunova: Why It’s Time to Close the Sex Variable Gap in Healthcare
Genoveva Uzunova, Former Senior Staff Associate at Columbia University in the City of New York, shared a post on LinkedIn:
“Today marks Sex Diff Day and Mental Health Awareness Week – a perfect time to discuss a gap in our healthcare system:
Sex as a Biological Variable (SABV).
As both a psychiatrist and a genetherapy researcher, I’ve seen how ignoring sex differences, from brain stereotaxic coordinates in the lab to diagnostic scales in the psychiatry clinic, may lead to missed targets and missed diagnoses.
In this video, I explore why men’s depression often ‘masks’ as irritability, and why structural brain differences mean we must move toward truly precision psychiatry.
We cannot provide better care until we do better, sex-specific science.
We know that the brains of female mice have many neuroanatomical and gene expression differences with the brains of male mice, which may translate into different behaviors.
Diseases such as depression, anxiety, autism, Alzheimer’s disease, multiple sclerosis, Systemic lupus erythematosus (SLE), and breast cancer have higher rates in women than in men.
In connection with today, my dear Mom, Anelia Uzunova, published a letter in Nature in 1976 with her co-authors Estelle Ramey and Peter Ramwell, on the Effect of testosterone, sex and age on experimentally induced arterial thrombosis.
My views in this presentation are based on my professional experience and literature searches.
I have discussed many of them, particularly relating to gene therapy and depression, with my supervisors but have met with some resistance as this will complicate the studies and work.
When I researched brain gene therapies for neurodegenerative disorders, I measured the Bregma-Lambda distances in our four transgenic mouse strains and found differences between strains and males and females.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy